Last week, a 9-0 Supreme Court ruled that human genes do not count as patent-eligible subject matter but that fake genes with some DNA missing may. Ass'n for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398, slip op. 12 (U.S. June 13, 2013) ("Groundbreaking, innovative, or even brilliant discovery does not by itself satisfy